Search Result

Search Result

Results for "

Hydroxyamphetamine

" in MCE Product Catalog:

By Targets:	Bradykinin Receptor (1) GCGR (1) Insulin Receptor (1) Isotope-Labeled Compounds (1) Somatostatin Receptor (3)
By Research Areas:	Cancer (3) Cardiovascular Disease (1) Endocrinology (1) Inflammation/Immunology (2) Metabolic Disease (2) Neurological Disease (3)

7

Inhibitors & Agonists

11

Peptides

1

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas

[Hyp3]-Bradykinin	Bradykinin Receptor	Endocrinology Cardiovascular Disease
[Hyp3]-Bradykinin, naturally occurring peptide hormone, is a bradykinin receptor agonist. [Hyp3]-Bradykinin interacts with B2-bradykinin receptors and stimulates inositol phosphate production in cultured human fibroblasts.

BIM-23190	Somatostatin Receptor	Cancer
BIM-23190, a somatostatin analog, a selective SSTR2 and SSTR5 agonist, exhibits K_i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly.

BIM-23190 hydrochloride	Somatostatin Receptor	Cancer
BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits K_i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly.

DA-JC4	Insulin Receptor	Inflammation/Immunology Neurological Disease
DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.

HY-P0014

Liraglutide
GCGR Metabolic Disease

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.

CH 275	Somatostatin Receptor	Neurological Disease
CH 275 is a peptide analog of somatostatin and binds preferably to somatostatin receptor 1 (sst₁) with a K_i of 52 nM. CH 275 acts as a potent and selective sst₁ agonist (IC₅₀=30.9 nM) and also displays IC₅₀ values of 345 nM, >1 μM, >10 μM, >10 μM for human sst₃, sst₄, sst₂ and sst₅, respectively. CH 275 can be used for the research of alzheimer’s disease.

HY-P0014S

Liraglutide-d8 triTFA
Isotope-Labeled Compounds Others

Liraglutide-d₈ (triTFA) is the deuterium labeled Liraglutide (HY-P0014)[1].

Cat. No.	Product Name	Target	Research Area

[Hyp3]-Bradykinin	Bradykinin Receptor	Endocrinology Cardiovascular Disease
[Hyp3]-Bradykinin, naturally occurring peptide hormone, is a bradykinin receptor agonist. [Hyp3]-Bradykinin interacts with B2-bradykinin receptors and stimulates inositol phosphate production in cultured human fibroblasts.

[Dehydro-Pro4] Substance P (4-11)	Peptides	Inflammation/Immunology Neurological Disease
[Dehydro-Pro4] Substance P (4-11) is a peptide fragment of Substance P. Substance P is a peptide mainly secreted by neurons. Substance P takes part in many biological processes, including nociception, inflammation and immunity.

Pep-1-Cysteamine	Peptides	Others
Pep-1-Cysteamine is a chimeric cell-penetrating peptide (CPP) with a primary amphipathicity. Pep-1-Cysteamine has the ability to translocate across biological membranes and introduce active proteins inside cells.

BIM-23190	Somatostatin Receptor	Cancer
BIM-23190, a somatostatin analog, a selective SSTR2 and SSTR5 agonist, exhibits K_i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly.

BIM-23190 hydrochloride	Somatostatin Receptor	Cancer
BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits K_i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly.

MAIT-203	Peptides	Cancer
MAIT-203, a cyclopentyalanin-derived peptidomimetic, potently inhibits the interaction of adenomatous polyposis coli (APC) and Asef (RhoGEF4), but not APC-Sam68 or APC-striatin interactions. MAIT-203 binds APC-ARM with a K_i of 0.015 μM and a K_d of 0.036 μM. MAIT-203 significantly represses the migration and invasion of colorectal cancer cells.

HY-P3714

p-Aminophenylacetyl-tuftsin
Peptides Others

p-Aminophenylacetyl-tuftsin is an active synthetic petide. p-Aminophenylacetyl-tuftsin can be used for the research of various diseases.

DA-JC4	Insulin Receptor	Inflammation/Immunology Neurological Disease
DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.

HY-P0014

Liraglutide
GCGR Metabolic Disease

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.

CH 275	Somatostatin Receptor	Neurological Disease
CH 275 is a peptide analog of somatostatin and binds preferably to somatostatin receptor 1 (sst₁) with a K_i of 52 nM. CH 275 acts as a potent and selective sst₁ agonist (IC₅₀=30.9 nM) and also displays IC₅₀ values of 345 nM, >1 μM, >10 μM, >10 μM for human sst₃, sst₄, sst₂ and sst₅, respectively. CH 275 can be used for the research of alzheimer’s disease.

HY-P4070

Insulin icodec
Peptides Metabolic Disease

Insulin icodec is a basal insulin analog. Insulin icodec can be used for the research of type 2 diabetes.

Cat. No.	Product Name

HY-P0014S

Liraglutide-d8 triTFA

Liraglutide-d₈ (triTFA) is the deuterium labeled Liraglutide (HY-P0014)[1].

MCE Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Literature; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Active Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2023 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us